FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2579488117> ?p ?o ?g. }

• W2579488117 endingPage "14394" @default.
• W2579488117 startingPage "14374" @default.
• W2579488117 abstract "// Claire Tonry 1 , John Armstrong 2 and Stephen R. Pennington 1 1 Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Co. Dublin 2 St. Luke’s Hospital, Rathgar, Dublin, Co. Dublin Correspondence to: Claire Tonry, email: // Keywords : prostate cancer; tumour microenvironment; biomarkers; proteomics; mass spectrometry Received : June 13, 2016 Accepted : October 19, 2016 Published : January 12, 2017 Abstract In the developed world, prostate cancer is the most common cancer diagnosis in men. Although prostate cancer initially presents as a non life-threatening disease, 90% of patients will develop castration resistant prostate cancer (CRPC), which preludes distant metastasis and is largely accountable for prostate cancer associated deaths. This is because as yet, there are no viable molecular therapeutic targets for effective treatment of CRPC. It is now widely accepted that cancer cells can alter their metabolic profile during the course of tumourgenesis and metastasis such that they are able to survive in oxygen and nutrient-poor environments. This work was aimed towards gaining greater mechanistic understanding of how such ‘stresses’ in the tumour microenvironment impact on both androgen sensitive (LNCaP) and androgen independent (LNCaP-abl and LNCaP-abl-Hof) prostate cancer cell lines. Here we have applied technically robust and reproducible label-free liquid chromatography mass spectrometry analysis for comprehensive proteomic profiling of prostate cancer cell lines under nutrient deficient (low glucose) conditions. This led to the identification of approximately 4,000 proteins - one of the largest protein datasets for prostate cancer cell lines established to date. The biological and clinical significance of proteins showing a significant change in expression as result of low glucose conditions was established. Novel, intuitive workflows were subsequently implemented to ensure the verification of selected proteins of interest in a robust, reproducible and high throughput manner. Overall, these data suggest that this strategy supports identification of protein biomarkers of prostate cancer progression and potential therapeutic targets for CRPC." @default.
• W2579488117 created "2017-01-26" @default.
• W2579488117 creator A5009871905 @default.
• W2579488117 creator A5025076109 @default.
• W2579488117 creator A5074326062 @default.
• W2579488117 date "2017-01-12" @default.
• W2579488117 modified "2023-09-26" @default.
• W2579488117 title "Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression" @default.
• W2579488117 cites W1501481238 @default.
• W2579488117 cites W1938785803 @default.
• W2579488117 cites W1963740134 @default.
• W2579488117 cites W1966576667 @default.
• W2579488117 cites W1967285376 @default.
• W2579488117 cites W1981187883 @default.
• W2579488117 cites W1985075679 @default.
• W2579488117 cites W1986057581 @default.
• W2579488117 cites W1986234170 @default.
• W2579488117 cites W1986870905 @default.
• W2579488117 cites W1996956937 @default.
• W2579488117 cites W2005658600 @default.
• W2579488117 cites W2008710073 @default.
• W2579488117 cites W2011356964 @default.
• W2579488117 cites W2015793742 @default.
• W2579488117 cites W2020142455 @default.
• W2579488117 cites W2021019297 @default.
• W2579488117 cites W2026707626 @default.
• W2579488117 cites W2033374599 @default.
• W2579488117 cites W2036809882 @default.
• W2579488117 cites W2037915750 @default.
• W2579488117 cites W2038009564 @default.
• W2579488117 cites W2042081254 @default.
• W2579488117 cites W2044190493 @default.
• W2579488117 cites W2046687522 @default.
• W2579488117 cites W2048219904 @default.
• W2579488117 cites W2054466780 @default.
• W2579488117 cites W2071973512 @default.
• W2579488117 cites W2078693224 @default.
• W2579488117 cites W2083003255 @default.
• W2579488117 cites W2090406819 @default.
• W2579488117 cites W2090642125 @default.
• W2579488117 cites W2095873383 @default.
• W2579488117 cites W2102819537 @default.
• W2579488117 cites W2104762821 @default.
• W2579488117 cites W2106376891 @default.
• W2579488117 cites W2107633226 @default.
• W2579488117 cites W2112861594 @default.
• W2579488117 cites W2116458487 @default.
• W2579488117 cites W2116516144 @default.
• W2579488117 cites W2119391023 @default.
• W2579488117 cites W2125042451 @default.
• W2579488117 cites W2127903786 @default.
• W2579488117 cites W2137140571 @default.
• W2579488117 cites W2139573571 @default.
• W2579488117 cites W2148004738 @default.
• W2579488117 cites W2153178365 @default.
• W2579488117 cites W2160074540 @default.
• W2579488117 cites W2161112598 @default.
• W2579488117 cites W2161817637 @default.
• W2579488117 cites W2163427033 @default.
• W2579488117 cites W2163471981 @default.
• W2579488117 cites W2164003677 @default.
• W2579488117 cites W2215122350 @default.
• W2579488117 cites W2480826285 @default.
• W2579488117 cites W2519688808 @default.
• W2579488117 cites W2984785086 @default.
• W2579488117 cites W89883982 @default.
• W2579488117 doi "https://doi.org/10.18632/oncotarget.14605" @default.
• W2579488117 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5362412" @default.
• W2579488117 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28086232" @default.
• W2579488117 hasPublicationYear "2017" @default.
• W2579488117 type Work @default.
• W2579488117 sameAs 2579488117 @default.
• W2579488117 citedByCount "7" @default.
• W2579488117 countsByYear W25794881172018 @default.
• W2579488117 countsByYear W25794881172019 @default.
• W2579488117 countsByYear W25794881172020 @default.
• W2579488117 crossrefType "journal-article" @default.
• W2579488117 hasAuthorship W2579488117A5009871905 @default.
• W2579488117 hasAuthorship W2579488117A5025076109 @default.
• W2579488117 hasAuthorship W2579488117A5074326062 @default.
• W2579488117 hasBestOaLocation W25794881171 @default.
• W2579488117 hasConcept C121608353 @default.
• W2579488117 hasConcept C126322002 @default.
• W2579488117 hasConcept C143998085 @default.
• W2579488117 hasConcept C2776107976 @default.
• W2579488117 hasConcept C2776235491 @default.
• W2579488117 hasConcept C2776438761 @default.
• W2579488117 hasConcept C2777899217 @default.
• W2579488117 hasConcept C2779013556 @default.
• W2579488117 hasConcept C2779723316 @default.
• W2579488117 hasConcept C2780192828 @default.
• W2579488117 hasConcept C502942594 @default.
• W2579488117 hasConcept C71924100 @default.
• W2579488117 hasConceptScore W2579488117C121608353 @default.
• W2579488117 hasConceptScore W2579488117C126322002 @default.
• W2579488117 hasConceptScore W2579488117C143998085 @default.
• W2579488117 hasConceptScore W2579488117C2776107976 @default.
• W2579488117 hasConceptScore W2579488117C2776235491 @default.

• next